| Dr James O Shirk, MD | |
|
1930 Alcoa Hwy Ste 240, Knoxville, TN 37920-1510 | |
| (865) 546-1642 | |
| (865) 305-6195 |
| Full Name | Dr James O Shirk |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 1930 Alcoa Hwy Ste 240, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154390649 | NPI | - | NPPES |
| Q007732 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25443 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Tn Medical Center | Knoxville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Health System, Inc. | 5294646378 | 526 |
News Archive
Traumatic brain injuries (TBIs) among children in China are a growing public health concern. Two new studies by researchers of the International Program at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital and the Wuhan Children's Hospital in China examined pediatric TBIs that were treated at Wuhan Children's Hospital from 2002 to 2011.
People with chronic kidney disease are at unusually high risk of also developing cardiovascular disease; in fact, a patient with non-dialysis kidney disease is more likely to die of heart failure than to develop end-stage kidney failure.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
David Isaacs, Professor of Pediatric Infectious Diseases at the University of Sydney, has called for the introduction of compensation for those who suffer a serious adverse reaction to vaccination.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
› Verified 2 days ago
| Entity Name | University Health System, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Traumatic brain injuries (TBIs) among children in China are a growing public health concern. Two new studies by researchers of the International Program at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital and the Wuhan Children's Hospital in China examined pediatric TBIs that were treated at Wuhan Children's Hospital from 2002 to 2011.
People with chronic kidney disease are at unusually high risk of also developing cardiovascular disease; in fact, a patient with non-dialysis kidney disease is more likely to die of heart failure than to develop end-stage kidney failure.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
David Isaacs, Professor of Pediatric Infectious Diseases at the University of Sydney, has called for the introduction of compensation for those who suffer a serious adverse reaction to vaccination.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
› Verified 2 days ago
| Entity Name | University Of Tennessee |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295751386 PECOS PAC ID: 3072421213 Enrollment ID: O20040110000145 |
News Archive
Traumatic brain injuries (TBIs) among children in China are a growing public health concern. Two new studies by researchers of the International Program at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital and the Wuhan Children's Hospital in China examined pediatric TBIs that were treated at Wuhan Children's Hospital from 2002 to 2011.
People with chronic kidney disease are at unusually high risk of also developing cardiovascular disease; in fact, a patient with non-dialysis kidney disease is more likely to die of heart failure than to develop end-stage kidney failure.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
David Isaacs, Professor of Pediatric Infectious Diseases at the University of Sydney, has called for the introduction of compensation for those who suffer a serious adverse reaction to vaccination.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James O Shirk, MD 1930 Alcoa Hwy Ste 240, Knoxville, TN 37920-1510 Ph: (865) 546-1642 | Dr James O Shirk, MD 1930 Alcoa Hwy Ste 240, Knoxville, TN 37920-1510 Ph: (865) 546-1642 |
News Archive
Traumatic brain injuries (TBIs) among children in China are a growing public health concern. Two new studies by researchers of the International Program at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital and the Wuhan Children's Hospital in China examined pediatric TBIs that were treated at Wuhan Children's Hospital from 2002 to 2011.
People with chronic kidney disease are at unusually high risk of also developing cardiovascular disease; in fact, a patient with non-dialysis kidney disease is more likely to die of heart failure than to develop end-stage kidney failure.
Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Company has secured approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements.
David Isaacs, Professor of Pediatric Infectious Diseases at the University of Sydney, has called for the introduction of compensation for those who suffer a serious adverse reaction to vaccination.
Sanofi announced today new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis (MF), a hematologic malignancy with unmet medical needs.
› Verified 2 days ago
Dr. Periclis Roussis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-331-2020 Fax: 865-331-2019 | |
Dr. George Walton Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-541-1975 Fax: 865-541-1976 | |
Dr. Roy Cox Broady, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th Street, Suite 509, Knoxville, TN 37916 Phone: 865-524-3208 Fax: 865-522-4322 | |
Courtney Roth, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1926 Alcoa Hwy Ste 370, Knoxville, TN 37920 Phone: 865-305-5622 | |
Dr. Lynlee Marie Wolfe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1925 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920 Phone: 865-305-8888 | |
Jeffrey A Keenan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11126 Kingston Pike, Knoxville, TN 37934 Phone: 865-777-0088 Fax: 865-777-2015 | |
Kristopher J. Kimball, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1934 Alcoa Hwy, Ste 478, Knoxville, TN 37920 Phone: 865-305-5622 Fax: 865-305-4580 |